[ad_1]
Sustainability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable treatment in type 2 diabetes (DUAL VIII): multicenter randomized controlled trial of phase 3b, open The Lancet
Sustainability of glycemic control could reduce the burden of disease and improve long-term outcomes. DUAL VIII has studied the durability of insulin degludec more …
[ad_2]Source link
